Understanding the Role of Risk Assessments for FDA Regulatory Submissions: A Key Step in Medical Device Success
November 15, 2024 | Regulatory Insights | Author: Neel [...]
What is FDA’s Standard of Appropriate for the Protection of Public Health?
July 30, 2024 - The following article was developed by [...]
Inter Scientific Completes Move To Expanded State-of-the-Art Laboratory Facility in Liverpool, UK
[EINPresswire.com] LIVERPOOL, UNITED KINGDOM -- 11 JUNE 2024 -- [...]
FDA, DOJ Form Task Force to Fight Illegal Vapes
Press Release from the Office of Public Affairs - [...]
FDA, DOJ Seize Over $700,000 Worth of Unauthorized E-Cigarettes
Information below has been directly sourced from U.S. Food [...]
Accorto Regulatory Solutions and Inter Scientific Enter Strategic Alliance to Deliver an Integrated Single-Point Solution for Clients
RICHMOND, VIRGINIA and LIVERPOOL, UNITED KINGDOM, Nov. 28, 2023 [...]
Accorto Announces Addition of Dr. Kevin Lye as Medical Advisor
RICHMOND, VIRGINIA - NOV. 24, 2023 At Accorto, we strive [...]
Use Of International Standard ISO 10993-1, “Biological Evaluation Of Medical Devices – Part 1: Evaluation And Testing Within A Risk Management Process” GalleryUse Of International Standard ISO 10993-1, “Biological Evaluation Of Medical Devices – Part 1: Evaluation And Testing Within A Risk Management Process”
-
Use Of International Standard ISO 10993-1, “Biological Evaluation Of Medical Devices – Part 1: Evaluation And Testing Within A Risk Management Process”
FDA has developed this guidance document to assist industry in [...]
CDRH Statement: FDA Continues To Take Steps To Strengthen The Premarket Notification [510(K)] Program
Today, the U.S. Food and Drug Administration issued three new [...]
What MoCRA Means for the US Cosmetics Industry
On December 29, 2022, the Modernization of Cosmetics Regulation [...]
